Literature DB >> 20080361

Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: the two sides of the same coin.

Stergios A Polyzos, Jannis Kountouras, Christos Zavos, Christos Stergiopoulos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20080361     DOI： 10.1016/j.mehy.2009.12.028

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN： 0306-9877            Impact factor:   1.538


× No keyword cloud information.
  6 in total

1.  The potentially dual-faceted nature of fetuin-A in Helicobacter pylori infection and insulin resistance.

Authors:  Stergios A Polyzos; Jannis Kountouras; Christos Zavos; Georgia Deretzi
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

2.  Adiponectin action: a combination of endocrine and autocrine/paracrine effects.

Authors:  Keith Dadson; Ying Liu; Gary Sweeney
Journal:  Front Endocrinol (Lausanne)       Date:  2011-11-08       Impact factor: 5.555

Review 3.  Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.

Authors:  Flavia A Cimini; Ilaria Barchetta; Simone Carotti; Laura Bertoccini; Marco G Baroni; Umberto Vespasiani-Gentilucci; Maria-Gisella Cavallo; Sergio Morini
Journal:  World J Gastroenterol       Date:  2017-05-21       Impact factor: 5.742

4.  Do symbiotic and Vitamin E supplementation have favorite effects in nonalcoholic fatty liver disease? A randomized, double-blind, placebo-controlled trial.

Authors:  Golnaz Ekhlasi; Roya Kolahdouz Mohammadi; Shahram Agah; Mitra Zarrati; Agha Fatemeh Hosseini; Seyed Soroush Soltani Arabshahi; Farzad Shidfar
Journal:  J Res Med Sci       Date:  2016-11-02       Impact factor: 1.852

Review 5.  Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease.

Authors:  Chrysoula Boutari; Nikolaos Perakakis; Christos Socrates Mantzoros
Journal:  Endocrinol Metab (Seoul)       Date:  2018-03

6.  Hepatic leptin receptor expression can partially compensate for IL-6Rα deficiency in DEN-induced hepatocellular carcinoma.

Authors:  Melanie J Mittenbühler; Hans-Georg Sprenger; Sabine Gruber; Claudia M Wunderlich; Lara Kern; Jens C Brüning; F Thomas Wunderlich
Journal:  Mol Metab       Date:  2018-09-05       Impact factor: 7.422
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.